SciELO - Scientific Electronic Library Online

 
vol.35 número6Evaluación de la función tiroidea, yoduria y estrés oxidativo en mujeres en el primer trimestre de embarazoAnálisis de las acciones de promoción de la actividad física desarrolladas por las universidades públicas valencianas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Nutrición Hospitalaria

versión On-line ISSN 1699-5198versión impresa ISSN 0212-1611

Resumen

LOERA-RODRIGUEZ, Luis Humberto de et al. Effect of symbiotic supplementation on fecal calprotectin levels and lactic acid bacteria, Bifidobacteria, Escherichia coli and Salmonella DNA in patients with cervical cancer. Nutr. Hosp. [online]. 2018, vol.35, n.6, pp.1394-1400.  Epub 03-Feb-2020. ISSN 1699-5198.  https://dx.doi.org/10.20960/nh.1762.

Background:

patients with cervical cancer (CC) receiving chemotherapy and radiotherapy have several gastrointestinal adverse effects.

Objective:

to evaluate the effect of dietary symbiotic supplementation on fecal calprotectin (FCP), bacterial DNA levels, and gastrointestinal adverse effects in patients with CC.

Methods:

clinical, controlled, randomized, double-blind trial. Patients consumed symbiotics or placebo three times a day for seven weeks. FCP was assessed by Elisa method. DNA from probiotic and pathogenic bacteria were determined by quantitative real-time polymerase chain reaction. Diarrheal evacuations were evaluated with the Bristol stool form scale and nausea and vomiting were measured using the scale of the National Institute of Cancerology of the United States.

Results:

after a seven-week treatment, FCP concentration was lower in the symbiotic group compared to the control group (p < 0.001). Stool consistency in the placebo and symbiotic groups was similar at baseline. A significant improvement in stool consistency was obtained in both groups at the end of the intervention (p < 0.001). The concentrations and total proportions of the probiotic and pathogenic bacteria were similar in both groups. Nausea significantly diminished in both groups (p < 0.001) at the end of the trial. Furthermore, the symbiotic group had a statistically significant decrease in the frequency and intensity of vomiting when compared to the control group (p < 0.001).

Conclusions:

the symbiotic treatment decreases significantly the FCP levels and the frequency and intensity of vomiting in patients with CC.

Palabras clave : Fecal calprotectin; Cervical cancer; Symbiotic; qPCR.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )